Cerity Partners
OM icon

Cerity Partners’s Outset Medical OM Stock Holding History

Cerity Partners’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.9K Buy
+12,737
New +$52.2K ﹤0.01% 3111
2023
Q1 		– Sell
-723
Closed -$280K – 1886
2022
Q4 		$280K Sell
723
-7
-1% -$1.97K ﹤0.01% 1173
2022
Q3 		$174K Buy
+730
New +$195K ﹤0.01% 1073

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Cerity Partners's OM Position: Q1 2026 in Review

Cerity Partners opened a new position in Outset Medical (OM) in Q1 2026: 12,737 shares worth $48.9K. The stake represents ﹤0.01% of the portfolio and ranks #3111 among its holdings. This is a return to the name: Cerity Partners previously reported a position in OM as recently as Q4 2022.

Cerity Partners first reported a position in OM in Q3 2022 and has held it in 3 quarters since. The position peaked at $280K in Q4 2022. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Cerity Partners held 12,737 shares of Outset Medical worth $48.9K as of Q1 2026.
  • Outset Medical was a new Cerity Partners position in Q1 2026.
  • Outset Medical made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #3111 holding.
  • Cerity Partners first reported a position in Outset Medical in Q3 2022 and has held it in 3 quarters since.
  • Cerity Partners's Outset Medical position peaked at $280K in Q4 2022.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.